Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1650 participants
OBSERVATIONAL
2017-03-05
2017-08-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Hypnoanalgesia for Dermatological Surgery in Children
NCT04707014
Non-operating Room Anesthesia Experiences in Pediatric Magnetic Resonance Imaging Cases
NCT05423821
The ED95 of Single Intravenous Bolus Remimazolam Besylate in Pediatric Patients During General Anesthesia Induction
NCT06061159
Remifentanil in Children With Obstructive Sleep Apnea
NCT03958396
Effects of Daily Interruption of Sedatives in Critically Ill Children
NCT00441506
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with neuromuscular block
Neuromuscular blocking agent administrated during surgery to the paediatric patient
Neuromuscular Blocking Agent
Administration of neuromuscular blockers during anesthesia
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Neuromuscular Blocking Agent
Administration of neuromuscular blockers during anesthesia
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* the study period (1/2016-12/2016)
* neuromuscular blocking agent administration during surgery
Exclusion Criteria
20 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Masaryk University
OTHER
Brno University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Petr Štourač, MD
doc. MD. Ph.D
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Brno University Hospital
Brno, , Czechia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KDAR FN Brno 3/2017
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.